Tourmaline Bio Ownership 2024 | Who Owns Tourmaline Bio Now?
Institutional Ownership
65.07%
Insider Ownership
11.91%
Retail Ownership
23.02%
Institutional Holders
49.00
Tourmaline Bio Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | - | - | - | -388,133 | -100.00% | - | Dec 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -10,571 | -100.00% | - | Dec 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -139 | -100.00% | - | Dec 31, 2023 |
| NORTHERN TRUST CORP | - | - | - | -30,458 | -100.00% | - | Dec 31, 2023 |
| STATE STREET CORP | - | - | - | -65,448 | -100.00% | - | Dec 31, 2023 |
| VANGUARD GROUP INC | - | - | - | -1,100,626 | -100.00% | - | Dec 31, 2023 |
| BARCLAYS PLC | - | - | - | -17,696 | -100.00% | - | Dec 31, 2023 |
| FMR LLC | - | - | - | -5,602 | -100.00% | - | Dec 31, 2023 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -272,773 | -100.00% | - | Dec 31, 2023 |
| PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -1,925 | -100.00% | - | Dec 31, 2023 |
| BAILARD, INC. | - | - | - | -14,773 | -100.00% | - | Dec 31, 2023 |
| CITIGROUP INC | - | - | - | -88 | -100.00% | - | Dec 31, 2023 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -13,707 | -100.00% | - | Dec 31, 2023 |
| GOLDMAN SACHS GROUP INC | - | - | - | -8,745 | -100.00% | - | Dec 31, 2023 |
| MORGAN STANLEY | - | - | - | -36,197 | -100.00% | - | Dec 31, 2023 |
| BANK OF MONTREAL /CAN/ | - | - | - | -12,500 | -100.00% | - | Dec 31, 2023 |
| NISA INVESTMENT ADVISORS, LLC | - | - | - | -72 | -100.00% | - | Dec 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -196,465 | -100.00% | - | Dec 31, 2023 |
| ARTAL GROUP S.A. | - | - | - | -914,262 | -100.00% | - | Dec 31, 2023 |
| FEDERATED HERMES, INC. | - | - | - | -2,350 | -100.00% | - | Dec 31, 2023 |
Tourmaline Bio's largest institutional shareholder is JPMORGAN CHASE & CO, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | - | - | - | -388,133 | -100.00% | - | Dec 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -10,571 | -100.00% | - | Dec 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -139 | -100.00% | - | Dec 31, 2023 |
| NORTHERN TRUST CORP | - | - | - | -30,458 | -100.00% | - | Dec 31, 2023 |
| STATE STREET CORP | - | - | - | -65,448 | -100.00% | - | Dec 31, 2023 |
| VANGUARD GROUP INC | - | - | - | -1,100,626 | -100.00% | - | Dec 31, 2023 |
| BARCLAYS PLC | - | - | - | -17,696 | -100.00% | - | Dec 31, 2023 |
| FMR LLC | - | - | - | -5,602 | -100.00% | - | Dec 31, 2023 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -272,773 | -100.00% | - | Dec 31, 2023 |
| PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -1,925 | -100.00% | - | Dec 31, 2023 |
| BAILARD, INC. | - | - | - | -14,773 | -100.00% | - | Dec 31, 2023 |
| CITIGROUP INC | - | - | - | -88 | -100.00% | - | Dec 31, 2023 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -13,707 | -100.00% | - | Dec 31, 2023 |
| GOLDMAN SACHS GROUP INC | - | - | - | -8,745 | -100.00% | - | Dec 31, 2023 |
| MORGAN STANLEY | - | - | - | -36,197 | -100.00% | - | Dec 31, 2023 |
| BANK OF MONTREAL /CAN/ | - | - | - | -12,500 | -100.00% | - | Dec 31, 2023 |
| NISA INVESTMENT ADVISORS, LLC | - | - | - | -72 | -100.00% | - | Dec 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -196,465 | -100.00% | - | Dec 31, 2023 |
| ARTAL GROUP S.A. | - | - | - | -914,262 | -100.00% | - | Dec 31, 2023 |
| FEDERATED HERMES, INC. | - | - | - | -2,350 | -100.00% | - | Dec 31, 2023 |
The largest Tourmaline Bio shareholder by % of total assets is JPMORGAN CHASE & CO. The company owns 0.00 shares of Tourmaline Bio (TALS), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NISA INVESTMENT ADVISORS, LLC | - | - | - | -72 | -100.00% | - | Dec 31, 2023 |
| CITIGROUP INC | - | - | - | -88 | -100.00% | - | Dec 31, 2023 |
| UBS GROUP AG | - | - | - | -139 | -100.00% | - | Dec 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -139 | -100.00% | - | Dec 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -962 | -100.00% | - | Dec 31, 2023 |
| RHUMBLINE ADVISERS | - | - | - | -1,164 | -100.00% | - | Dec 31, 2023 |
| PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -1,925 | -100.00% | - | Dec 31, 2023 |
| FEDERATED HERMES, INC. | - | - | - | -2,350 | -100.00% | - | Dec 31, 2023 |
| FMR LLC | - | - | - | -5,602 | -100.00% | - | Dec 31, 2023 |
| GOLDMAN SACHS GROUP INC | - | - | - | -8,745 | -100.00% | - | Dec 31, 2023 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -10,078 | -100.00% | - | Dec 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -10,571 | -100.00% | - | Dec 31, 2023 |
| BANK OF MONTREAL /CAN/ | - | - | - | -12,500 | -100.00% | - | Dec 31, 2023 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -13,707 | -100.00% | - | Dec 31, 2023 |
| BAILARD, INC. | - | - | - | -14,773 | -100.00% | - | Dec 31, 2023 |
| BARCLAYS PLC | - | - | - | -17,696 | -100.00% | - | Dec 31, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -20,689 | -100.00% | - | Dec 31, 2023 |
| XTX TOPCO LTD | - | - | - | -21,651 | -100.00% | - | Dec 31, 2023 |
| NORTHERN TRUST CORP | - | - | - | -30,458 | -100.00% | - | Dec 31, 2023 |
| MORGAN STANLEY | - | - | - | -36,197 | -100.00% | - | Dec 31, 2023 |
As of Dec 31 2023, Tourmaline Bio's largest institutional buyer is NISA INVESTMENT ADVISORS, LLC. The company purchased -72.00 stocks of TALS, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKSTONE INC. | - | - | - | -8,089,315 | -100.00% | - | Dec 31, 2023 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | - | - | - | -2,953,129 | -100.00% | - | Dec 31, 2023 |
| QIMING U.S. VENTURES MANAGEMENT, LLC | - | - | - | -2,932,606 | -100.00% | - | Dec 31, 2023 |
| RA CAPITAL MANAGEMENT, L.P. | - | - | - | -2,403,238 | -100.00% | - | Dec 31, 2023 |
| BML CAPITAL MANAGEMENT, LLC | - | - | - | -2,000,000 | -100.00% | - | Dec 31, 2023 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -1,465,602 | -100.00% | - | Dec 31, 2023 |
| VANGUARD GROUP INC | - | - | - | -1,100,626 | -100.00% | - | Dec 31, 2023 |
| GREAT POINT PARTNERS LLC | - | - | - | -1,000,000 | -100.00% | - | Dec 31, 2023 |
| ARTAL GROUP S.A. | - | - | - | -914,262 | -100.00% | - | Dec 31, 2023 |
| QVT FINANCIAL LP | - | - | - | -589,314 | -100.00% | - | Dec 31, 2023 |
| AVORO CAPITAL ADVISORS LLC | - | - | - | -500,000 | -100.00% | - | Dec 31, 2023 |
| AFFINITY ASSET ADVISORS, LLC | - | - | - | -400,000 | -100.00% | - | Dec 31, 2023 |
| JPMORGAN CHASE & CO | - | - | - | -388,133 | -100.00% | - | Dec 31, 2023 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -301,175 | -100.00% | - | Dec 31, 2023 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -272,773 | -100.00% | - | Dec 31, 2023 |
| WALLEYE CAPITAL LLC | - | - | - | -262,469 | -100.00% | - | Dec 31, 2023 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -246,030 | -100.00% | - | Dec 31, 2023 |
| TWO SIGMA ADVISERS, LP | - | - | - | -226,627 | -100.00% | - | Dec 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -205,814 | -100.00% | - | Dec 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -196,465 | -100.00% | - | Dec 31, 2023 |
As of Dec 31 2023, Tourmaline Bio's biggest institutional seller is BLACKSTONE INC.. The company sold -8.09M shares of TALS, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKSTONE INC. | - | - | - | -8,089,315 | -100.00% | - | Dec 31, 2023 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | - | - | - | -2,953,129 | -100.00% | - | Dec 31, 2023 |
| QIMING U.S. VENTURES MANAGEMENT, LLC | - | - | - | -2,932,606 | -100.00% | - | Dec 31, 2023 |
| RA CAPITAL MANAGEMENT, L.P. | - | - | - | -2,403,238 | -100.00% | - | Dec 31, 2023 |
| BML CAPITAL MANAGEMENT, LLC | - | - | - | -2,000,000 | -100.00% | - | Dec 31, 2023 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -1,465,602 | -100.00% | - | Dec 31, 2023 |
| VANGUARD GROUP INC | - | - | - | -1,100,626 | -100.00% | - | Dec 31, 2023 |
| GREAT POINT PARTNERS LLC | - | - | - | -1,000,000 | -100.00% | - | Dec 31, 2023 |
| ARTAL GROUP S.A. | - | - | - | -914,262 | -100.00% | - | Dec 31, 2023 |
| QVT FINANCIAL LP | - | - | - | -589,314 | -100.00% | - | Dec 31, 2023 |
| AVORO CAPITAL ADVISORS LLC | - | - | - | -500,000 | -100.00% | - | Dec 31, 2023 |
| AFFINITY ASSET ADVISORS, LLC | - | - | - | -400,000 | -100.00% | - | Dec 31, 2023 |
| JPMORGAN CHASE & CO | - | - | - | -388,133 | -100.00% | - | Dec 31, 2023 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -301,175 | -100.00% | - | Dec 31, 2023 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -272,773 | -100.00% | - | Dec 31, 2023 |
| WALLEYE CAPITAL LLC | - | - | - | -262,469 | -100.00% | - | Dec 31, 2023 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -246,030 | -100.00% | - | Dec 31, 2023 |
| TWO SIGMA ADVISERS, LP | - | - | - | -226,627 | -100.00% | - | Dec 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -205,814 | -100.00% | - | Dec 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -196,465 | -100.00% | - | Dec 31, 2023 |
| ACUITAS INVESTMENTS, LLC | - | - | - | -194,547 | -100.00% | - | Dec 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -157,645 | -100.00% | - | Dec 31, 2023 |
| BLACKROCK INC. | - | - | - | -126,831 | -100.00% | - | Dec 31, 2023 |
| CITADEL ADVISORS LLC | - | - | - | -114,482 | -100.00% | - | Dec 31, 2023 |
| STATE STREET CORP | - | - | - | -65,448 | -100.00% | - | Dec 31, 2023 |
| MAN GROUP PLC | - | - | - | -50,343 | -100.00% | - | Dec 31, 2023 |
| MARQUETTE ASSET MANAGEMENT, LLC | - | - | - | -40,028 | -100.00% | - | Dec 31, 2023 |
| MORGAN STANLEY | - | - | - | -36,197 | -100.00% | - | Dec 31, 2023 |
| NORTHERN TRUST CORP | - | - | - | -30,458 | -100.00% | - | Dec 31, 2023 |
| XTX TOPCO LTD | - | - | - | -21,651 | -100.00% | - | Dec 31, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -20,689 | -100.00% | - | Dec 31, 2023 |
| BARCLAYS PLC | - | - | - | -17,696 | -100.00% | - | Dec 31, 2023 |
| BAILARD, INC. | - | - | - | -14,773 | -100.00% | - | Dec 31, 2023 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -13,707 | -100.00% | - | Dec 31, 2023 |
| BANK OF MONTREAL /CAN/ | - | - | - | -12,500 | -100.00% | - | Dec 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -10,571 | -100.00% | - | Dec 31, 2023 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -10,078 | -100.00% | - | Dec 31, 2023 |
| GOLDMAN SACHS GROUP INC | - | - | - | -8,745 | -100.00% | - | Dec 31, 2023 |
| FMR LLC | - | - | - | -5,602 | -100.00% | - | Dec 31, 2023 |
| FEDERATED HERMES, INC. | - | - | - | -2,350 | -100.00% | - | Dec 31, 2023 |
| PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -1,925 | -100.00% | - | Dec 31, 2023 |
| RHUMBLINE ADVISERS | - | - | - | -1,164 | -100.00% | - | Dec 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -962 | -100.00% | - | Dec 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -139 | -100.00% | - | Dec 31, 2023 |
| UBS GROUP AG | - | - | - | -139 | -100.00% | - | Dec 31, 2023 |
| CITIGROUP INC | - | - | - | -88 | -100.00% | - | Dec 31, 2023 |
| NISA INVESTMENT ADVISORS, LLC | - | - | - | -72 | -100.00% | - | Dec 31, 2023 |
Tourmaline Bio's largest sold out institutional shareholder by shares sold is BLACKSTONE INC., sold -8.09M shares, valued at -, as of undefined.
Tourmaline Bio Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BlackRock Health Sciences Trust II | 0.28% | 748,614 | - | - | Mar 31, 2024 |
| Vericimetry Funds | 0.17% | 15,540 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.13% | 301,175 | - | - | Mar 28, 2024 |
| BlackRock Health Sciences Trust | 0.09% | 23,939 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.05% | 24,089 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 3,330 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 32,454 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 593 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,058,967 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 187,792 | - | - | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,647 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 17,570 | - | - | Mar 31, 2024 |
| BlackRock ETF Trust | 0.00% | 381 | - | - | Jan 31, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 1,561,092 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 13,707 | - | - | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 8,090 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,022 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 495 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 6,869 | 5,499 | 401.39% | Jan 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 14,773 | - | - | Jan 31, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 12,324 | - | - | Mar 28, 2024 |
| NORTHERN FUNDS | 0.00% | 12,419 | - | - | Mar 28, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,793 | - | - | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 4,800 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 29,391 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 6,473 | - | - | Feb 29, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 202,770 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 210 | - | - | Dec 31, 2023 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 82,096 | - | - | Feb 29, 2024 |
| VALIC Co I | 0.00% | 8,489 | - | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 800 | - | - | Mar 28, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 3,651 | - | - | Mar 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 3,300 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 314 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 291 | - | - | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 98 | - | - | Dec 31, 2023 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 24,028 | - | - | Jan 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 124 | - | - | Feb 29, 2024 |
| Dimensional ETF Trust | 0.00% | 8,350 | -3,492 | -29.49% | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 19,066 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 41,369 | - | - | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 13 | - | - | Dec 31, 2023 |
| PROSHARES TRUST | 0.00% | 2,728 | - | - | Feb 29, 2024 |
| Brighthouse Funds Trust II | 0.00% | 9,003 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 1,280 | -197 | -13.36% | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 2,148 | - | - | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 8,584 | -7,979 | -48.17% | Jan 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 849 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 1,785 | 1,550 | 659.57% | Jan 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 2,643 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 6,049 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 108 | - | - | Jan 31, 2024 |
| iSHARES TRUST | 0.00% | 71,670 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 200 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 776 | - | - | Jan 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 1,785 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 7,510 | - | - | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 4,187 | - | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 2,399 | - | - | Mar 31, 2024 |
| Meeder Funds | 0.00% | 4 | - | - | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 3,504 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 4,424 | - | - | Mar 28, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 937 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 2,185 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 6,800 | - | - | Feb 29, 2024 |
Tourmaline Bio's largest mutual fund holder by % of total assets is "BlackRock Health Sciences Trust II", owning 748.61K shares, compromising 0.28% of its total assets.
Tourmaline Bio Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Sep, 23 | 49 | -14.04% |
| 30 Jun, 23 | 57 | 9.62% |
| 31 Mar, 23 | 52 | - |
| 31 Dec, 22 | 52 | 1.96% |
| 30 Sep, 22 | 51 | -8.93% |
| 30 Jun, 22 | 56 | 9.80% |
| 31 Mar, 22 | 51 | - |
| 31 Dec, 21 | 51 | 6.25% |
| 30 Sep, 21 | 48 | -4.00% |
| 30 Jun, 21 | 50 | - |
As of 30 Sep 23, 49 institutions are holding Tourmaline Bio's shares, representing a decrease of -14.04% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Sep, 23 | 27,440,971 | 4.73% |
| 30 Jun, 23 | 26,201,061 | -2.66% |
| 31 Mar, 23 | 26,917,771 | 0.37% |
| 31 Dec, 22 | 26,819,729 | -1.70% |
| 30 Sep, 22 | 27,283,278 | -5.52% |
| 30 Jun, 22 | 28,878,772 | -0.96% |
| 31 Mar, 22 | 29,159,055 | -2.38% |
| 31 Dec, 21 | 29,870,725 | 15.46% |
| 30 Sep, 21 | 25,871,219 | -0.41% |
| 30 Jun, 21 | 25,977,876 | - |
Tourmaline Bio (TALS) has 27.44M shares outstanding as of 30 Sep 23, up 4.73% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Sep, 23 | 65.07% | 1.66% |
| 30 Jun, 23 | 62.69% | 1.51% |
| 31 Mar, 23 | 64.40% | 1.52% |
| 31 Dec, 22 | 65.02% | 1.50% |
| 30 Sep, 22 | 65.94% | 1.33% |
| 30 Jun, 22 | 70.28% | 1.39% |
| 31 Mar, 22 | 71.15% | 1.32% |
| 31 Dec, 21 | 73.45% | 1.82% |
| 30 Sep, 21 | 63.61% | 0.71% |
| 30 Jun, 21 | 94.90% | - |
As of 30 Sep 23, Tourmaline Bio is held by 65.07% institutional shareholders, representing a 1.66% growth compared to 30 Jun 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Sep, 23 | 17 | -46.88% |
| 30 Jun, 23 | 32 | 23.08% |
| 31 Mar, 23 | 26 | -7.14% |
| 31 Dec, 22 | 28 | 7.69% |
| 30 Sep, 22 | 26 | 30.00% |
| 30 Jun, 22 | 20 | -4.76% |
| 31 Mar, 22 | 21 | -36.36% |
| 31 Dec, 21 | 33 | 57.14% |
| 30 Sep, 21 | 21 | -58.00% |
| 30 Jun, 21 | 50 | - |
17 institutional shareholders have increased their position in TALS stock as of 30 Sep 23 compared to 32 in the previous quarter (a -46.88% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Sep, 23 | 18 | -10.00% |
| 30 Jun, 23 | 20 | 53.85% |
| 31 Mar, 23 | 13 | 30.00% |
| 31 Dec, 22 | 10 | -16.67% |
| 30 Sep, 22 | 12 | -42.86% |
| 30 Jun, 22 | 21 | 50.00% |
| 31 Mar, 22 | 14 | 100.00% |
| 31 Dec, 21 | 7 | -46.15% |
| 30 Sep, 21 | 13 | - |
| 30 Jun, 21 | - | - |
18 institutional shareholders have reduced their position in TALS stock as of 30 Sep 23 compared to 20 in the previous quarter (a -10.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Sep, 23 | 49 | -14.04% | 27,440,971 | 4.73% | 65.07% | 1.66% | 17 | -46.88% | 18 | -10.00% |
| 30 Jun, 23 | 57 | 9.62% | 26,201,061 | -2.66% | 62.69% | 1.51% | 32 | 23.08% | 20 | 53.85% |
| 31 Mar, 23 | 52 | - | 26,917,771 | 0.37% | 64.40% | 1.52% | 26 | -7.14% | 13 | 30.00% |
| 31 Dec, 22 | 52 | 1.96% | 26,819,729 | -1.70% | 65.02% | 1.50% | 28 | 7.69% | 10 | -16.67% |
| 30 Sep, 22 | 51 | -8.93% | 27,283,278 | -5.52% | 65.94% | 1.33% | 26 | 30.00% | 12 | -42.86% |
| 30 Jun, 22 | 56 | 9.80% | 28,878,772 | -0.96% | 70.28% | 1.39% | 20 | -4.76% | 21 | 50.00% |
| 31 Mar, 22 | 51 | - | 29,159,055 | -2.38% | 71.15% | 1.32% | 21 | -36.36% | 14 | 100.00% |
| 31 Dec, 21 | 51 | 6.25% | 29,870,725 | 15.46% | 73.45% | 1.82% | 33 | 57.14% | 7 | -46.15% |
| 30 Sep, 21 | 48 | -4.00% | 25,871,219 | -0.41% | 63.61% | 0.71% | 21 | -58.00% | 13 | - |
| 30 Jun, 21 | 50 | - | 25,977,876 | - | 94.90% | - | 50 | - | - | - |
Tourmaline Bio Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Tourmaline Bio's stock was made by Srivastava Sapna on Oct 23 2023, selling 20,500 shares at $2.54 per share (valued at $52.07K). The last insider buy of TALS was made by Kulkarni Sandeep Chidambar on Nov 20 2023, buying 4,000 shares at $16.99 per share (worth $67.96K).
Tourmaline Bio Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q4 2023 | 40 | 2 | 2000.00% |
| Q3 2023 | - | 2 | - |
| Q2 2023 | 8 | 15 | 53.33% |
| Q1 2023 | 8 | 12 | 66.67% |
| Q4 2022 | 1 | - | - |
| Q3 2022 | 13 | 4 | 325.00% |
| Q2 2022 | 8 | - | - |
| Q1 2022 | 5 | - | - |
| Q4 2021 | 4 | 2 | 200.00% |
| Q2 2021 | 44 | 29 | 151.72% |
40 total buy trades, and 2 total sell trades (buy/sell ratio of 20.00%) were made by Tourmaline Bio's insiders, as of Q4 2023.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q4 2023 | 9 | - | - |
| Q3 2023 | - | - | - |
| Q2 2023 | - | 15 | - |
| Q1 2023 | - | 12 | - |
| Q4 2022 | - | - | - |
| Q3 2022 | 7 | 1 | 700.00% |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q2 2021 | 16 | - | - |
As of Q4 2023, Insider owners conducted 9 open market buy trades and 0 open market sell trades of Tourmaline Bio's stocks.
Tourmaline Bio Peer Ownership
| Ticker | Company |
|---|---|
| NUVB | Nuvation Bio Inc. |
| CGEM | Cullinan Oncology, Inc. |
| ACHL | Achilles Therapeutics plc |
| NXTC | NextCure, Inc. |
| VOR | Vor Biopharma Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| CTMX | CytomX Therapeutics, Inc. |
| SPRO | Spero Therapeutics, Inc. |
| CNTB | Connect Biopharma Holdings Limited |
| ASMB | Assembly Biosciences, Inc. |
| OVID | Ovid Therapeutics Inc. |
| NLTX | Neurogene Inc. |
| ACET | Adicet Bio, Inc. |
| TIL | Instil Bio, Inc. |
TALS Ownership FAQ
Who Owns Tourmaline Bio?
Tourmaline Bio is owned by institutional shareholders (65.07%), insiders (11.91%), and public (23.02%). The largest institutional shareholder of Tourmaline Bio is JPMORGAN CHASE & CO (0% of total shares) and the top mutual fund owner is BlackRock Health Sciences Trust II (0.28% of total shares).
Who are the major institutional shareholders of Tourmaline Bio?
Tourmaline Bio's major institutional shareholders are JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, and STATE STREET CORP. The top five shareholders own together 0% of the company's share outstanding.
How many Tourmaline Bio shareholders are there?
As of Sep 2023, there are 49 institutional shareholders of Tourmaline Bio.
What percentage of Tourmaline Bio is owned by JPMORGAN CHASE & CO?
JPMORGAN CHASE & CO owns 0 shares of Tourmaline Bio, representing 0% of the company's total shares outstanding, valued at $0 (as of Dec 2023).
What percentage of Tourmaline Bio is owned by BANK OF AMERICA CORP /DE/?
As of Dec 2023, BANK OF AMERICA CORP /DE/ holds 0 shares of Tourmaline Bio (TALS), compromising 0% of the company, valued at $0.
What percentage of Tourmaline Bio is owned by WELLS FARGO & COMPANY/MN?
WELLS FARGO & COMPANY/MN is the third largest holder of Tourmaline Bio. The company owns 0 of the company's shares outstanding (worth $0).